Oman vs Qatar: Tuberculosis patients living with HIV receiving antiretroviral therapy
Oman
4 patients
in 2021
Qatar
3 patients
in 2021
Oman rank
115th
Qatar rank
117th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Oman
- Qatar
How they compare
Oman currently reports 4 patients against 3 patients in Qatar, a difference of 1 patients.
That makes Oman's figure about 1.3 times Qatar's.
The two have swapped places 1 time across 18 shared years of data; in 2003 it was Qatar ahead.
Oman ranks 115th and Qatar ranks 117th of 183 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.5 patients | 0.3333 patients | 7.17 patients | Oman |
| 2010s | 6.2 patients | 0.3 patients | 5.9 patients | Oman |
| 2020s | 6 patients | 2.5 patients | 3.5 patients | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Oman or Qatar?
- Oman, at 4 patients against 3 patients in Qatar as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Oman and Qatar?
- 1 patients, with Oman ahead.
- How many years of comparable data are there for Oman and Qatar?
- 18 years are reported by both, from 2003 to 2021.
- How do Oman and Qatar rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Oman ranks 115th and Qatar ranks 117th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.